About half the company was bought overnight for no less than US2.78 per 10 shares, so maybe we have a floor?
Other than that, the best I can hope for is that PBT2 helps a subset of sufferers in a clinically significant way, and that the right analysis (additional trial?) will show that. Maybe too optimistic for now?
Another little gem for next time... don't use PBT2 as agent AND placebo! What, too soon?
About half the company was bought overnight for no less than...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $20.84K | 4.709M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 59 | 71059076 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 28775923 | 21 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |